Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-26 @ 2:22 AM
NCT ID:
NCT03389802
Pre Assignment Details:
Patients with recurrent or refractory primary malignant CNS tumors were enrolled on stratum 1, and patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG) were enrolled on stratum 2. A total of 32 patients were enrolled (31 eligible). Twenty-one (21) stratum 1 patients were enrolled; 1 of these patients was deemed to be ineligible as an eligibility assessment was not performed. Eleven (11) stratum 2 patients were enrolled (all deemed eligible).
Recruitment Details:
Patients ≥1 and ≤21 years of age with recurrent or refractory primary malignant central nervous system (CNS) tumors (Stratum 1) or newly diagnosed diffuse intrinsic pontine glioma (DIPG) (Stratum 2) were enrolled at Pediatric Brain Tumor Consortium (PBTC) member institutions. The first patient was enrolled on 3/1/2018 and the last patient was enrolled on 1/20/2023. Accrual was closed after the maximum tolerated dose/recommended phase II dose was determined for both strata.
Study:
NCT03389802
Study Brief:
Results Section:
NCT03389802